Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-20

Clinical Trial Update: VOLT CE Mark Study [NA]

View source ↗

Summary

Abbott Medical Devices is conducting the VOLT CE Mark Study for atrial arrhythmia and atrial fibrillation, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOLT

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Arrhythmia, Atrial Fibrillation | NA | Status: RECRUITING